{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:15:50Z","timestamp":1793646950565,"version":"4.5.1"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cellimm.2022.104527","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:07:06Z","timestamp":1650539226000},"page":"104527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["TREX1 plays multiple roles in human diseases"],"prefix":"10.1016","volume":"375","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucheng","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5833-1852","authenticated-orcid":false,"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2022.104527_b0005","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1093\/emboj\/18.13.3868","article-title":"A human DNA editing enzyme homologous to the Escherichia coli DnaQ\/MutD protein","volume":"18","author":"H\u00f6ss","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.cellimm.2022.104527_b0010","doi-asserted-by":"crossref","first-page":"19655","DOI":"10.1074\/jbc.274.28.19655","article-title":"Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'\u2013>5' exonucleases","volume":"274","author":"Mazur","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104527_b0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","article-title":"Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease","volume":"131","author":"Yang","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104527_b0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cellimm.2022.104527_b0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Gouti\u00e8res syndrome at the AGS1 locus","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104527_b0030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cellimm.2022.104527_b0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513443","article-title":"Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome","volume":"80","author":"Rice","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104527_b0040","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ng2082","article-title":"C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy","volume":"39","author":"Richards","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2022.104527_b0045","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104527_b0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1 , RNASEH2A , RNASEH2B , RNASEH2C , SAMHD1 , ADAR , and IFIH1","volume":"167","author":"Crow","year":"2015","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.cellimm.2022.104527_b0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12969-020-00423-y","article-title":"Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome","volume":"18","author":"Yi","year":"2020","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.cellimm.2022.104527_b0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2133.2012.10813.x","article-title":"Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Gouti\u00e8res syndrome","volume":"167","author":"T\u00fcngler","year":"2012","journal-title":"Brit. J. Dermatol."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104527_b0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-007-0199-9","article-title":"A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus","volume":"85","author":"Lee-Kirsch","year":"2007","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"issue":"10","key":"10.1016\/j.cellimm.2022.104527_b0070","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/ajmg.a.33620","article-title":"A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Gouti\u00e8res syndrome","volume":"152A","author":"Haaxma","year":"2010","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.cellimm.2022.104527_b0075","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/kes181","article-title":"Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome\/familial chilblain lupus","volume":"52","author":"Abe","year":"2013","journal-title":"Rheumatology (Oxford, England)"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104527_b0080","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2013.04.020","article-title":"Systemic involvement in TREX1-associated familial chilblain lupus","volume":"69","author":"G\u00fcnther","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104527_b0085","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejmg.2017.09.004","article-title":"A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis","volume":"60","author":"Kisla Ekinci","year":"2017","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.cellimm.2022.104527_b0090","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.27367","article-title":"Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutieres syndrome","volume":"62","author":"Ramantani","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellimm.2022.104527_b0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/rheumatology\/ket372","article-title":"A nationwide survey of Aicardi-Gouti\u00e8res syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study","volume":"53","author":"Abe","year":"2014","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.cellimm.2022.104527_b0100","first-page":"699","article-title":"Different Clinical Manifestations of Three Prime Repair Exonuclease 1 Mutation: A Case Series, Annals of Indian Academy of","volume":"23","author":"Incecik","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cellimm.2022.104527_b0105","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1038\/jid.2012.210","article-title":"Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3'-repair exonuclease 1","volume":"132","author":"Sugiura","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2022.104527_b0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamadermatol.2014.3438","article-title":"Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1)","volume":"151","author":"G\u00fcnther","year":"2015","journal-title":"JAMA Dermatol."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104527_b0115","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1136\/ard.2009.114157","article-title":"TREX1 gene variant in neuropsychiatric systemic lupus erythematosus","volume":"69","author":"de Vries","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104527_b0120","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104527_b0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-1119(95)00530-J","article-title":"The 3'-5' exonuclease site of DNA polymerase III from gram-positive bacteria: definition of a novel motif structure","volume":"165","author":"Barnes","year":"1995","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11752","article-title":"RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA","volume":"7","author":"Wolf","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104527_b0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.stem.2017.07.009","article-title":"Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 accumulation as a source of neuroinflammation","volume":"21","author":"Thomas","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.cellimm.2022.104527_b0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/08916934.2018.1522305","article-title":"TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis","volume":"51","author":"Rego","year":"2018","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104527_b0150","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.molcel.2020.12.037","article-title":"ER-directed TREX1 limits cGAS activation at micronuclei","volume":"81","author":"Mohr","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2006.06.005","article-title":"The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death","volume":"23","author":"Chowdhury","year":"2006","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.cellimm.2022.104527_b0160","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1074\/jbc.M700039200","article-title":"The crystal structure of TREX1 explains the 3' nucleotide specificity and reveals a polyproline II helix for protein partnering","volume":"282","author":"de Silva","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.dnarep.2011.10.007","article-title":"Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease","volume":"11","author":"Bailey","year":"2012","journal-title":"DNA Repair"},{"issue":"5","key":"10.1016\/j.cellimm.2022.104527_b0170","doi-asserted-by":"crossref","first-page":"e2005653","DOI":"10.1371\/journal.pbio.2005653","article-title":"Structural basis for overhang excision and terminal unwinding of DNA duplexes by TREX1","volume":"16","author":"Huang","year":"2018","journal-title":"PLoS Biol."},{"issue":"17","key":"10.1016\/j.cellimm.2022.104527_b0175","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00555-21","article-title":"Human Three Prime Repair Exonuclease 1 Promotes HIV-1 Integration by Preferentially Degrading Unprocessed Viral DNA","volume":"95","author":"Davids","year":"2021","journal-title":"J. Virol."},{"issue":"52","key":"10.1016\/j.cellimm.2022.104527_b0180","doi-asserted-by":"crossref","first-page":"49283","DOI":"10.1074\/jbc.M107779200","article-title":"Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase eta and resistance to exonuclease action at cyclopurine deoxynucleoside residues","volume":"276","author":"Kuraoka","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104527_b0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.mad.2006.12.005","article-title":"WRN exonuclease activity is blocked by DNA termini harboring 3' obstructive groups","volume":"128","author":"Harrigan","year":"2007","journal-title":"Mech. Ageing Dev."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104527_b0190","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.immuni.2013.08.004","article-title":"Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing","volume":"39","author":"Gehrke","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2022.104527_b0195","doi-asserted-by":"crossref","first-page":"32373","DOI":"10.1074\/jbc.M111.276287","article-title":"Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome","volume":"286","author":"Fye","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.cellimm.2022.104527_b0200","doi-asserted-by":"crossref","first-page":"31649","DOI":"10.1074\/jbc.M806155200","article-title":"The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease","volume":"283","author":"Lehtinen","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104527_b0205","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ni.1941","article-title":"The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1","volume":"11","author":"Yan","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6121","key":"10.1016\/j.cellimm.2022.104527_b0210","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"6121","key":"10.1016\/j.cellimm.2022.104527_b0215","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2022.104527_b0220","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.1400737","article-title":"TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner","volume":"192","author":"Ablasser","year":"2014","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"issue":"2015","key":"10.1016\/j.cellimm.2022.104527_b0225","first-page":"1939","article-title":"Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Gouti\u00e8res Syndrome","volume":"195","author":"Gray","year":"1950","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.cellimm.2022.104527_b0230","doi-asserted-by":"crossref","first-page":"E5699","DOI":"10.1073\/pnas.1516465112","article-title":"Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases","volume":"112","author":"Gao","year":"2015","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104527_b0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molcel.2021.01.024","article-title":"cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing","volume":"81","author":"Zhou","year":"2021","journal-title":"Mol Cell."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104527_b0240","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/jir.2016.0086","article-title":"Immune diseases associated with TREX1 and STING dysfunction","volume":"37","author":"Yan","year":"2017","journal-title":"J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.cellimm.2022.104527_b0245","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1093\/nar\/gkx178","article-title":"Aicardi-Goutieres syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion","volume":"45","author":"Li","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellimm.2022.104527_b0250","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.celrep.2013.08.019","article-title":"Modulation of LINE-1 and Alu\/SVA retrotransposition by Aicardi-Goutieres syndrome-related SAMHD1","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/nar\/gkw834","article-title":"ADAR1 restricts LINE-1 retrotransposition","volume":"45","author":"Orecchini","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.cellimm.2022.104527_b0260","doi-asserted-by":"crossref","first-page":"e1005367","DOI":"10.1371\/journal.pgen.1005367","article-title":"SAMHD1 Inhibits LINE-1 Retrotransposition by Promoting Stress Granule Formation","volume":"11","author":"Hu","year":"2015","journal-title":"PLoS Genet."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104527_b0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10409238.2021.1893640","article-title":"HIV suppressors against LINE-1: one functions as two","volume":"56","author":"Du","year":"2021","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"7870","key":"10.1016\/j.cellimm.2022.104527_b0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-021-03542-y","article-title":"The role of retrotransposable elements in ageing and age-associated diseases","volume":"596","author":"Gorbunova","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0275","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.genet.35.102401.091032","article-title":"Biology of mammalian L1 retrotransposons","volume":"35","author":"Ostertag","year":"2001","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.cellimm.2022.104527_b0280","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaut.2018.02.007","article-title":"LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways","volume":"90","author":"Zhao","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2022.104527_b0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-4690-8-91","article-title":"An autoimmune disease prevented by anti-retroviral drugs","volume":"8","author":"Beck-Engeser","year":"2011","journal-title":"Retrovirology"},{"issue":"2017","key":"10.1016\/j.cellimm.2022.104527_b0290","first-page":"2261","article-title":"Lack of Trex1 causes systemic autoimmunity despite the presence of antiretroviral drugs","volume":"199","author":"Achleitner","year":"1950","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.cellimm.2022.104527_b0295","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/BST0370535","article-title":"Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease","volume":"37","author":"Lindahl","year":"2009","journal-title":"Biochem. Soc. Trans."},{"issue":"20","key":"10.1016\/j.cellimm.2022.104527_b0300","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1016\/j.cell.2021.08.035","article-title":"Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion","volume":"184","author":"Nader","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellimm.2022.104527_b0305","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2015.07.022","article-title":"Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation","volume":"43","author":"Hasan","year":"2015","journal-title":"Immunity"},{"issue":"38","key":"10.1016\/j.cellimm.2022.104527_b0310","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1073\/pnas.1806034115","article-title":"Mammalian STT3A\/B oligosaccharyltransferases segregate N-glycosylation at the translocon from lipid-linked oligosaccharide hydrolysis","volume":"115","author":"Lu","year":"2018","journal-title":"PNAS"},{"issue":"2-3","key":"10.1016\/j.cellimm.2022.104527_b0315","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-510X(88)90125-6","article-title":"Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy","volume":"84","author":"Lebon","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cellimm.2022.104527_b0320","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of Aicardi-Goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104527_b0325","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"The Lancet Neurol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0330","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410150109","article-title":"A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis","volume":"15","author":"Aicardi","year":"1984","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104527_b0335","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng1842","article-title":"Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Gouti\u00e8res syndrome and mimic congenital viral brain infection","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2022.104527_b0340","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng.373","article-title":"Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response","volume":"41","author":"Rice","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2022.104527_b0345","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104527_b0350","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng.2933","article-title":"Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling","volume":"46","author":"Rice","year":"2014","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104527_b0355","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41588-020-00737-3","article-title":"cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing","volume":"52","author":"Uggenti","year":"2020","journal-title":"Nat. Genet."},{"issue":"1 Regulatory Fu","key":"10.1016\/j.cellimm.2022.104527_b0360","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1980.tb20602.x","article-title":"Interferon-induced disease in mice and rats","volume":"350","author":"Gresser","year":"1980","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cellimm.2022.104527_b0365","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/MCB.24.15.6719-6727.2004","article-title":"Gene-targeted mice lacking the Trex1 (DNase III) 3'\u2013>5' DNA exonuclease develop inflammatory myocarditis","volume":"24","author":"Morita","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104527_b0370","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/bpa.12600","article-title":"Astrocytes, an active player in Aicardi-Gouti\u00e8res syndrome","volume":"28","author":"Sase","year":"2018","journal-title":"Brain pathology (Zurich, Switzerland)"},{"key":"10.1016\/j.cellimm.2022.104527_b0375","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Goutieres syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2022.104527_b0380","doi-asserted-by":"crossref","unstructured":"R.A. Elbarbary, B.A. Lucas, L.E. Maquat, Retrotransposons as regulators of gene expression, Science, 351 (2016) aac7247. https:\/\/doi.org\/10.1126\/science.aac7247.","DOI":"10.1126\/science.aac7247"},{"issue":"16","key":"10.1016\/j.cellimm.2022.104527_b0385","doi-asserted-by":"crossref","first-page":"11556","DOI":"10.1074\/jbc.M114.559252","article-title":"The Arg-62 residues of the TREX1 exonuclease act across the dimer interface contributing to catalysis in the opposing protomers","volume":"289","author":"Fye","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2022.104527_b0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11926-017-0689-x","article-title":"Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?","volume":"19","author":"Fiehn","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cellimm.2022.104527_b0395","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann. NY Acad. Sci."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104527_b0400","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/507848","article-title":"Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p","volume":"79","author":"Lee-Kirsch","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104527_b0405","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00415-013-7084-y","article-title":"A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus","volume":"260","author":"Yamashiro","year":"2013","journal-title":"J. Neurol."},{"issue":"16","key":"10.1016\/j.cellimm.2022.104527_b0410","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1073\/pnas.1423804112","article-title":"Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease","volume":"112","author":"Grieves","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.cellimm.2022.104527_b0415","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2017.10.008","article-title":"Monogenic lupus: it's all new!","volume":"49","author":"Costa-Reis","year":"2017","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"10.1016\/j.cellimm.2022.104527_b0420","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10875-015-0147-3","article-title":"Human disease phenotypes associated with mutations in TREX1","volume":"35","author":"Rice","year":"2015","journal-title":"J Clin Immunol"},{"issue":"10188","key":"10.1016\/j.cellimm.2022.104527_b0425","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.cellimm.2022.104527_b0430","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2014.10.005","article-title":"Type I interferonopathies: mendelian type I interferon up-regulation","volume":"32","author":"Crow","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2022.104527_b0435","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144918","article-title":"Bite of the wolf: innate immune responses propagate autoimmunity in lupus","volume":"131","author":"Gupta","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellimm.2022.104527_b0440","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2019.03.001","article-title":"cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model","volume":"100","author":"Xiao","year":"2019","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0445","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2011.11.018","article-title":"Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease","volume":"36","author":"Gall","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2022.104527_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/reumatismo.2015.782","article-title":"Typing TREX1 gene in patients with systemic lupus erythematosus","volume":"67","author":"Fredi","year":"2015","journal-title":"Reumatismo"},{"key":"10.1016\/j.cellimm.2022.104527_b0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/471703","article-title":"Rare variants in the TREX1 gene and susceptibility to autoimmune diseases","volume":"2013","author":"Barizzone","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104527_b0460","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.celrep.2017.02.051","article-title":"Mitotic Phosphorylation of TREX1 C Terminus Disrupts TREX1 Regulation of the Oligosaccharyltransferase Complex","volume":"18","author":"Kucej","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2022.104527_b0465","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2017.03.001","article-title":"DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice","volume":"81","author":"Sakai","year":"2017","journal-title":"J. Autoimmun."},{"issue":"2019","key":"10.1016\/j.cellimm.2022.104527_b0470","first-page":"2276","article-title":"Intra- and extracellular degradation of neutrophil extracellular traps by macrophages and dendritic cells","volume":"203","author":"Lazzaretto","year":"1950","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.cellimm.2022.104527_b0475","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2990.2010.01147.x","article-title":"Review: molecular genetics and pathology of hereditary small vessel diseases of the brain","volume":"37","author":"Yamamoto","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.cellimm.2022.104527_b0480","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2022.104527_b0485","first-page":"323","article-title":"TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of","volume":"36","author":"DiFrancesco","year":"2015","journal-title":"Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104527_b0490","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/ETLS20170063","article-title":"TREX1 is a checkpoint for innate immune sensing of DNA damage that fosters cancer immune resistance","volume":"1","author":"Marincola","year":"2017","journal-title":"Emerging Topics Life Sci."},{"issue":"9-10","key":"10.1016\/j.cellimm.2022.104527_b0495","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1101\/gad.348314.121","article-title":"Interfaces between cellular responses to DNA damage and cancer immunotherapy","volume":"35","author":"Pilger","year":"2021","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104527_b0500","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"IF32-STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2022.104527_b0505","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"2014","key":"10.1016\/j.cellimm.2022.104527_b0510","first-page":"6124","article-title":"STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells","volume":"193","author":"Klarquist","year":"1950","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"issue":"8","key":"10.1016\/j.cellimm.2022.104527_b0515","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41422-020-0346-1","article-title":"Old dogs, new trick: classic cancer therapies activate cGAS","volume":"30","author":"Yum","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cellimm.2022.104527_b0520","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1093\/nar\/gkq455","article-title":"Three prime exonuclease I (TREX1) is Fos\/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage","volume":"38","author":"Christmann","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0525","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1189\/jlb.2A0713-393RR","article-title":"TLR ligands up-regulate Trex1 expression in murine conventional dendritic cells through type I Interferon and NF-\u03baB-dependent signaling pathways","volume":"96","author":"Xu","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2022.104527_b0530","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semcdb.2021.03.021","article-title":"Genome instability from nuclear catastrophe and DNA damage","volume":"123","author":"Mammel","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"issue":"7383","key":"10.1016\/j.cellimm.2022.104527_b0535","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10802","article-title":"DNA breaks and chromosome pulverization from errors in mitosis","volume":"482","author":"Crasta","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0540","doi-asserted-by":"crossref","first-page":"188661","DOI":"10.1016\/j.bbcan.2021.188661","article-title":"Genomic instability, inflammatory signaling and response to cancer immunotherapy","volume":"1877","author":"Chen","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Reviews on Cancer"},{"issue":"7","key":"10.1016\/j.cellimm.2022.104527_b0545","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41556-020-0537-5","article-title":"Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation","volume":"22","author":"Vietri","year":"2020","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.cellimm.2022.104527_b0550","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature14493","article-title":"Chromothripsis from DNA damage in micronuclei","volume":"522","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"7668","key":"10.1016\/j.cellimm.2022.104527_b0555","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2022.104527_b0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2018.11.001","article-title":"The molecular origins and pathophysiological consequences of micronuclei: new insights into an age-old problem","volume":"779","author":"Guo","year":"2019","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104527_b0565","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41577-021-00568-1","article-title":"Immunomodulation by radiotherapy in tumour control and normal tissue toxicity","volume":"22","author":"Cytlak","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2022.104527_b0570","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148274","article-title":"The abscopal effect: a sense of DNA damage is in the air","volume":"131","author":"Lippert","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellimm.2022.104527_b0575","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2017.12.007","article-title":"Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers","volume":"52","author":"Lhuillier","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"13","key":"10.1016\/j.cellimm.2022.104527_b0580","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2217\/fon-2020-0994","article-title":"The abscopal effect of radiation therapy","volume":"17","author":"Craig","year":"2021","journal-title":"Future Oncol. (London, England)"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104527_b0585","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1101\/gad.289769.116","article-title":"A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1","volume":"31","author":"Erdal","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellimm.2022.104527_b0590","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fonc.2012.00153","article-title":"Radiation as an immunological adjuvant: current evidence on dose and fractionation","volume":"2","author":"Demaria","year":"2012","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104527_b0595","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.trecan.2016.05.002","article-title":"Radiotherapy: changing the game in immunotherapy","volume":"2","author":"Demaria","year":"2016","journal-title":"Trends Cancer"},{"issue":"8","key":"10.1016\/j.cellimm.2022.104527_b0600","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tcb.2017.06.001","article-title":"TREX1 cuts down on cancer immunogenicity","volume":"27","author":"Yamazaki","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"22","key":"10.1016\/j.cellimm.2022.104527_b0605","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/j.devcel.2021.11.003","article-title":"TREX1-dependent DNA damage links nuclear rupture to tumor cell invasion","volume":"56","author":"Gomes","year":"2021","journal-title":"Dev. Cell"},{"issue":"7","key":"10.1016\/j.cellimm.2022.104527_b0610","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.cell.2015.11.054","article-title":"Chromothripsis and Kataegis Induced by Telomere Crisis","volume":"163","author":"Maciejowski","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.cellimm.2022.104527_b0615","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41588-020-0667-5","article-title":"APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis","volume":"52","author":"Maciejowski","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2022.104527_b0620","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.671297","article-title":"The last chance saloon","volume":"9","author":"Hong","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6488","key":"10.1016\/j.cellimm.2022.104527_b0625","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba0712","article-title":"Mechanisms generating cancer genome complexity from a single cell division error","volume":"368","author":"Umbreit","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cellimm.2022.104527_b0630","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0092-8674(03)00150-8","article-title":"Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor","volume":"112","author":"Fan","year":"2003","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.cellimm.2022.104527_b0635","doi-asserted-by":"crossref","first-page":"13344","DOI":"10.1074\/jbc.M115.653915","article-title":"Human DNA exonuclease TREX1 is also an exoribonuclease that acts on single-stranded RNA","volume":"290","author":"Yuan","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.cellimm.2022.104527_b0640","doi-asserted-by":"crossref","first-page":"28881","DOI":"10.1074\/jbc.M113.503391","article-title":"The TREX1 C-terminal region controls cellular localization through ubiquitination","volume":"288","author":"Orebaugh","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2022.104527_b0645","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13018-016-0487-6","article-title":"Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma","volume":"11","author":"Feng","year":"2016","journal-title":"J. Orthopae. Surg. Res."},{"key":"10.1016\/j.cellimm.2022.104527_b0650","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000452281","article-title":"DNA-sensing and nuclease gene expressions as markers for colorectal cancer progression","volume":"92","author":"Yang","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.cellimm.2022.104527_b0655","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41598-018-37064-x","article-title":"Three Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo","volume":"9","author":"Prati","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2022.104527_b0660","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20202603","article-title":"Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma","volume":"40","author":"Qi","year":"2020","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104527_b0665","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1080\/21655979.2021.1972198","article-title":"Carboplatin activates the cGAS-STING pathway by upregulating the TREX-1 (three prime repair exonuclease 1) expression in human melanoma","volume":"12","author":"Ma","year":"2021","journal-title":"Bioengineered"},{"issue":"7","key":"10.1016\/j.cellimm.2022.104527_b0670","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc.2017.35","article-title":"Transposable elements in cancer","volume":"17","author":"Burns","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.cellimm.2022.104527_b0675","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.3390\/cancers13174452","article-title":"Nucleic Acid Sensing in the Tumor Vasculature","volume":"13","author":"Baris","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cellimm.2022.104527_b0680","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1038\/ncomms13597","article-title":"MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment","volume":"7","author":"Wilson","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492200051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492200051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:09:24Z","timestamp":1757804964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887492200051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":136,"alternative-id":["S000887492200051X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104527","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TREX1 plays multiple roles in human diseases","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104527"}}